Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Lwanga

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
African Health Sciences|April 18, 2006
A renal aspergilloma--an unusual presentation of aspergillosis in an HIV patientDavid Meya, Isaac Lwanga, Allan Ronald, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasisJens Van Roey, Myriam Haxaire, Moses Kamya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2015
Strengthening the "Viral Failure Pathway": Clinical Decision and Outcomes of Patients With Confirmed Viral Failure in a Large HIV Care Clinic in UgandaBarbara Castelnuovo, Mark Nsumba, Rachel Musomba, et al.
AIDS Care|December 19, 2019
Implementing routine physical function screening among elderly HIV-positive patients in UgandaIsaac Lwanga, Maria Sarah Nabaggala, Agnes Kiragga, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2014
Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, UgandaAggrey S Semeere, Isaac Lwanga, Joseph Sempa, et al.
AIDS Research and Therapy|July 4, 2026
Brief communication: clinical jaundice is associated with poor adherence to boosted atazanavir among adults in an HIV clinic in Kampala, UgandaAngella Nabakooza, Sharon Kitibwakye Nakamanya, Eva Agnes Laker, et al.
The Journal of Infection|March 9, 2019
Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinicsFred S Sarfo, Barbara Castelnuovo, Iuri Fanti, et al.
Drug Safety|September 14, 2020
The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir-Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by WomenEva Agnes Odongpiny Laker, Arnold Arinaitwe, Noela Owarwo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
African Health Sciences|April 18, 2006
A renal aspergilloma--an unusual presentation of aspergillosis in an HIV patientDavid Meya, Isaac Lwanga, Allan Ronald, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasisJens Van Roey, Myriam Haxaire, Moses Kamya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2015
Strengthening the "Viral Failure Pathway": Clinical Decision and Outcomes of Patients With Confirmed Viral Failure in a Large HIV Care Clinic in UgandaBarbara Castelnuovo, Mark Nsumba, Rachel Musomba, et al.
AIDS Care|December 19, 2019
Implementing routine physical function screening among elderly HIV-positive patients in UgandaIsaac Lwanga, Maria Sarah Nabaggala, Agnes Kiragga, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2014
Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, UgandaAggrey S Semeere, Isaac Lwanga, Joseph Sempa, et al.
AIDS Research and Therapy|July 4, 2026
Brief communication: clinical jaundice is associated with poor adherence to boosted atazanavir among adults in an HIV clinic in Kampala, UgandaAngella Nabakooza, Sharon Kitibwakye Nakamanya, Eva Agnes Laker, et al.
The Journal of Infection|March 9, 2019
Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinicsFred S Sarfo, Barbara Castelnuovo, Iuri Fanti, et al.
Drug Safety|September 14, 2020
The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir-Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by WomenEva Agnes Odongpiny Laker, Arnold Arinaitwe, Noela Owarwo, et al.
Pageof 1